This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Which Low Fee Index Funds Offer Best Value 2024 compares low-cost funds to help you pick the best value for retirement goals.
27,292 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
AI momentum has pushed markets higher, but one stock stands out as a potential tech stock with eyes. This piece break...
Palantir just posted its first $1B-plus quarter, pushing it into the world’s top-25 by market value and redefining th...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
When a hedge fund boosts its holdings, investors pay attention. This piece explains why Bridge City nearly tripled it...
In 2026, Sharplink makes its first Ethereum purchase, signaling a calculated pivot in treasury strategy. This article...
Bezos pushes back on Mamdani’s tactic of painting opponents as villains, arguing real solutions require skill. The NY...
A bold AI-based forecast from Meta envisions Bitcoin surging toward multi-year highs by year-end 2026, anchored by re...
The House rejected a bill to fund the Smithsonian American Women’s History Museum, triggering a partisan clash that l...
Institutional optimism around Ethereum is rising as new neutral stewardship groups launch and major firms signal inte...
A fresh briefing from the Joint Economic Committee shows Medicare Advantage overpayments totaling about $7 billion pe...
NVIDIA’s push beyond chips is drawing investor attention to life sciences. This article breaks down what Jensen Huang...